Clinical trials recruiting in Compiègne, France
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 3Not applicable 5
Conditions recruiting in Compiègne, France
Recruiting trials in Compiègne, France
- Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- DESTINY Breast Respond HER2-(Ultra)Low Europe
- Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study
- PRostate Olaparib Real World Evidence Study
- Prospective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With MSI/dMMR Metastatic Colorectal Cancer (CORESIM)
- Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer
- REBECCA Real-world Early BrEast CanCer mAnagement
Common questions
How many clinical trials are recruiting in Compiègne, France?
8 recruiting trials have at least one study site in Compiègne, France.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.